A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1997
12/09/1997	US5695749 Oil-free edible bar comprising anticholesterol agent and starch, bran filler
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045367A1 Dissolvable oxides for biological applications
12/04/1997	WO1997045139A2 Il-12 as an adjuvant for bordetella pertussis vaccines
12/04/1997	WO1997045138A1 New improved formulation for treatment of thromboembolism
12/04/1997	WO1997045135A1 Stable pharmaceutical composition of bdnf
12/04/1997	WO1997045132A1 Antiviral agent, process for production thereof, and application thereof
12/04/1997	WO1997045124A1 Pharmaceutical compositions
12/04/1997	WO1997045123A1 Topical pharmaceutical formulations comprising aciclovir
12/04/1997	WO1997045122A1 Suppositories
12/04/1997	WO1997045121A1 Preparation for percutaneous administration
12/04/1997	WO1997045117A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	WO1997045102A1 Novel therapeutic use of ophthalmic gels
12/04/1997	WO1997045069A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	WO1997038679A3 Fast disintegrating oral dosage form
12/04/1997	WO1997037689A3 Denaturants for sympathomimetic amine salts
12/04/1997	WO1997035568A3 Diclofenac/gamma-cyclodextrin inclusion compounds
12/04/1997	WO1997026919A3 Method of imaging amyloid deposits
12/04/1997	CA2256900A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	CA2256669A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
12/04/1997	CA2253410A1 New improved formulation for treatment of thromboembolism
12/03/1997	EP0809996A2 Interferon conjugates
12/03/1997	EP0809705A1 Nucleic acid-containing composition, preparation and use thereof
12/03/1997	EP0809628A1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides
12/03/1997	EP0809623A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
12/03/1997	EP0809515A1 Therapeutic inhibitor of vascular smooth muscle cells
12/03/1997	EP0809514A1 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid
12/03/1997	EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
12/03/1997	EP0809506A2 Antimicrobial composition composed of controlled release glasses
12/03/1997	EP0809501A1 Novel pharmaceutical formulation
12/03/1997	EP0809498A1 Novel pharmaceutical combination
12/03/1997	EP0809487A1 Solid active agent preparations containing hydroxypropyl cellulose
12/03/1997	EP0809486A1 Bio-erodible ophthalmic shield
12/03/1997	EP0797433A4 Gas filled microspheres as magnetic resonance imaging contrast agents
12/03/1997	EP0719286B1 Dextran esters, process for producing them and their use for encasing and encapsulating medicaments
12/03/1997	EP0627939B1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
12/03/1997	EP0533838B1 Nucleic acid ligands
12/03/1997	CN1166787A Lubeluzole intravenous solutions
12/03/1997	CN1166505A Absorbable copolymers and blends of 6,6,-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
12/03/1997	CN1166361A Solvent for saponin powder for injecta
12/02/1997	US5693788 Desiccation and prevention of retrogradation using trehalose
12/02/1997	US5693764 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
12/02/1997	US5693760 Specific amino acid sequence consisting of position 2-135 includes a glycosylation site within position 96-98, binds beta-glalactoside containing moieties independent of absence of presence of calcium ions, stimulates hemagglutination
12/02/1997	US5693751 Water soluble high molecular weight polymerized drug preparation
12/02/1997	US5693677 Soluble, stable skin moisturizers
12/02/1997	US5693627 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/02/1997	US5693625 Administering dextran functionalized with carboxymethyl groups and benzylamide or benzylamide sulfonate groups to skin or cornea
12/02/1997	US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/02/1997	US5693608 Method of administering a biologically active substance
12/02/1997	US5693513 Adding base to gel-forming aqueous acidic solution of hydrolyzed organosilicon and immediately mixing with hank's balanced salt solution containing cells, casting into container
12/02/1997	US5693341 Premixing a polyanionic carbohydrate and positively charged active protein in the absence of collagen, forming a stable complexes
12/02/1997	US5693340 Diffusion-inhibiting, adhesive coating layer comprising chemical network having carbon or carbon and silicon atoms in chemically crosslinked relation
12/02/1997	US5693338 Delivery composition comprising active agent, diketopiperazine, enzyme inhibitor
12/02/1997	US5693337 Stable lipid emulsion
12/02/1997	US5693335 Using a mixture of (1) a polyhydric thioalcohol having at least one mercapto and one hydroxy group and (2) a fatty acid or ester; transdermal patches; estrogen therapy
12/02/1997	US5693326 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
12/02/1997	US5693321 Polymers containing diester units
12/02/1997	US5693319 Polyamines and method for preparation thereof
12/02/1997	US5693312 Pharmaceutical composition having analgesic activity
12/02/1997	US5693255 Oil-in-water type emulsion composition
12/02/1997	US5693034 Lubricous polymer network
12/02/1997	CA2052679C Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
11/1997
11/27/1997	WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997	WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	WO1997044064A2 Oligonucleotides which specifically bind retroviral nucleocapsid proteins
11/27/1997	WO1997044063A2 Dha-pharmaceutical agent conjugates
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997044039A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
11/27/1997	WO1997044026A1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
11/27/1997	WO1997044023A1 Pharmaceutical compositions based on diclofenac
11/27/1997	WO1997044021A1 Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
11/27/1997	WO1997044017A1 Effervescent bisphosphonate formulation
11/27/1997	WO1997044016A1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
11/27/1997	WO1997044015A1 Microparticles and their use in wound therapy
11/27/1997	WO1997044014A1 Antifungal compositions with improved bioavailability
11/27/1997	WO1997044013A1 Aerodynamically light particles for pulmonary drug delivery
11/27/1997	WO1997044009A1 Cosmetic or pharmaceutical preparations with a reduced feeling of stickiness
11/27/1997	WO1997043989A1 Compositions, methods and devices for the transdermal delivery of drugs
11/27/1997	WO1997039739A3 Polyol composition
11/27/1997	WO1997039738A3 Sustained release ionic conjugate
11/27/1997	WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997	DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997	DE19620341A1 Medicine for treating geriatric complaints by percutaneous resorption
11/27/1997	CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997	CA2256365A1 Compositions, methods and devices for the transdermal delivery of drugs
11/27/1997	CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	CA2255822A1 Oligonucleotides which specifically bind retroviral nucleocapsid proteins
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	CA2253874A1 Viral particles which are masked or unmasked with respect to a cell receptor
11/26/1997	EP0809110A1 Macromolecular microparticles and methods of production
11/26/1997	EP0808629A1 Sucralfate preparation
11/26/1997	EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS
11/26/1997	EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
11/26/1997	EP0808332A1 Method for preparing collagen from cnidarians, and resulting cosmetic compositions
11/26/1997	EP0808174A1 Medicament in particle form
11/26/1997	EP0808156A1 Compositions comprising nanoparticles of nsaid
11/26/1997	EP0808155A1 Sugar base surfactant for nanocrystals

1 ... 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 ... 1712